Illinois Municipal Retirement Fund Acquires 54,229 Shares of Ralliant Corporation $RAL

Illinois Municipal Retirement Fund grew its holdings in shares of Ralliant Corporation (NYSE:RAL) by 1,156.3% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 58,919 shares of the company’s stock after acquiring an additional 54,229 shares during the period. Illinois Municipal Retirement Fund’s holdings in Ralliant were worth $2,577,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently modified their holdings of RAL. ING Groep NV lifted its position in Ralliant by 1,169.2% during the third quarter. ING Groep NV now owns 122,367 shares of the company’s stock valued at $5,351,000 after purchasing an additional 112,726 shares in the last quarter. Versor Investments LP bought a new position in shares of Ralliant in the third quarter worth about $2,261,000. Oppenheimer Asset Management Inc. purchased a new position in shares of Ralliant during the 3rd quarter valued at about $396,000. Smartleaf Asset Management LLC purchased a new position in shares of Ralliant during the 3rd quarter valued at about $83,000. Finally, Canada Post Corp Registered Pension Plan bought a new position in shares of Ralliant during the 3rd quarter valued at approximately $72,000.

Wall Street Analyst Weigh In

RAL has been the topic of a number of recent analyst reports. Vertical Research upgraded shares of Ralliant from a “hold” rating to a “buy” rating and set a $45.00 target price on the stock in a research note on Friday, February 6th. Barclays decreased their price objective on shares of Ralliant from $60.00 to $52.00 and set an “overweight” rating on the stock in a research report on Monday, February 9th. Morgan Stanley reaffirmed an “overweight” rating and issued a $45.00 target price on shares of Ralliant in a report on Friday, February 6th. Truist Financial cut their price target on Ralliant from $62.00 to $49.00 and set a “buy” rating for the company in a research note on Friday, February 6th. Finally, Royal Bank Of Canada decreased their price target on Ralliant from $52.00 to $41.00 and set a “sector perform” rating on the stock in a report on Friday, February 6th. Seven equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $50.50.

Insider Activity

In other Ralliant news, Director Anelise Angelino Sacks bought 2,000 shares of the business’s stock in a transaction dated Monday, February 9th. The shares were purchased at an average price of $41.25 per share, with a total value of $82,500.00. Following the completion of the purchase, the director owned 5,403 shares in the company, valued at $222,873.75. This represents a 58.77% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, SVP Amir A. Kazmi purchased 2,545 shares of Ralliant stock in a transaction dated Friday, February 6th. The stock was acquired at an average price of $39.27 per share, for a total transaction of $99,942.15. Following the completion of the acquisition, the senior vice president owned 39,699 shares of the company’s stock, valued at approximately $1,558,979.73. This trade represents a 6.85% increase in their position. The SEC filing for this purchase provides additional information. Insiders have bought a total of 8,145 shares of company stock worth $332,233 over the last 90 days.

Ralliant Stock Up 3.4%

Shares of NYSE:RAL opened at $44.03 on Monday. The company has a market cap of $4.97 billion and a price-to-earnings ratio of 22.46. Ralliant Corporation has a 12 month low of $37.27 and a 12 month high of $57.02. The company has a 50-day moving average price of $50.79 and a 200 day moving average price of $46.56. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.38.

Ralliant (NYSE:RAL) last announced its earnings results on Wednesday, February 4th. The company reported $0.69 EPS for the quarter, topping analysts’ consensus estimates of $0.67 by $0.02. The company had revenue of $554.60 million during the quarter, compared to analysts’ expectations of $543.04 million. The company’s revenue for the quarter was up 1.2% on a year-over-year basis. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, March 23rd. Stockholders of record on Monday, March 9th will be paid a $0.05 dividend. The ex-dividend date of this dividend is Monday, March 9th. This represents a $0.20 annualized dividend and a dividend yield of 0.5%. Ralliant’s dividend payout ratio is currently 10.20%.

Ralliant News Summary

Here are the key news stories impacting Ralliant this week:

• Positive Sentiment: Directors/insiders bought stock this week (Kate Mitchell bought 2,350 shares at ~$42.48; Anelise Angelino Sacks bought ~2,000 shares), a signal often read as confidence in the company and a near‑term support for the share price. InsiderTrades: Kate Mitchell Acquires 2,350 Shares The Motley Fool: Director Scoops Up 2,000 Shares
• Neutral Sentiment: Recent quarterly results beat consensus (EPS and revenue) and the company provided Q1 and FY 2026 guidance — fundamentals remain mixed and will be watched closely but are not a new surprise. MarketBeat: Ralliant Earnings & Guidance
• Negative Sentiment: Multiple law firms have publicly opened or promoted investigations into possible securities‑law violations tied to Ralliant (Kaplan Fox, Kirby McInerney, Kessler Topaz, Block & Leviton and others). Those actions increase litigation and regulatory risk and can pressure the stock as legal costs, disclosures and management distraction unfold. Globe and Mail: Kaplan Fox Alert GlobeNewswire: Kirby McInerney Alert
• Negative Sentiment: Ongoing negative analyst moves, higher short interest and prior material non‑cash impairment/guidance reductions (reported earlier) raise downside risk and intraday volatility — these factors can offset positive insider signals and lead to further selling on adverse updates. Kessler Topaz PR Business Insider: Block & Leviton Alert

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.